![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 22, 17058-17063, June 2, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the
Department of Microbiology, Faculty of
Pharmaceutical Sciences, Okayama University, Tsushima, Okayama,
700-8530 Japan and the § School of Biosciences, The
University of Birmingham, Edgbaston, Birmingham B15 2TT, United
Kingdom
Received for publication, January 22, 2000, and in revised form, March 10, 2000
| |
ABSTRACT |
|---|
|
|
|---|
MelR is an Escherichia coli
transcription factor that activates expression of the melAB
operon in response to the presence of melibiose in the environment.
MelR stimulates transcription initiation at the melAB
promoter by binding to four sites centered at positions Melibiose metabolism by Escherichia coli is contingent
on expression of the melA and melB genes, that
are cotranscribed from a single promoter in response to the presence of
melibiose in the growth medium: melA encodes an
Transcription initiation at the melAB promoter is totally
dependent on MelR, a melibiose-triggered transcription activator (8).
MelR is encoded by the melR gene, which is located
immediately upstream of the melA gene, and transcribed from
a promoter that is divergent from the melAB promoter (the
transcription start points of the melAB and melR
promoters are 237 bases apart; see Fig. 1) (9). MelR is a member of the
AraC family of transcription factors and binds to 18-base pair target
sequences (10). At the melAB promoter, MelR binds to four
such target sequences: site 1', site 1, site 2, and site 2' centered at
positions Subcloning the mel Operon Regulatory Region--
Plasmids
pBM3133, carrying the entire wild type mel operon, and
pBM3133-2, carrying the mel operon from the W3133-2 mutant, were described in our previous study (7).
EcoRI-HindIII fragments, carrying the wild type
or mutant mel operon regulatory region, were derived using
polymerase chain reaction (PCR) using pBM3133 or pBM3133-2 as
templates. The KK81 fragment, carrying an EcoRI site at
position In Vivo Expression Assays--
The KK81 or JK14
EcoRI-HindIII fragments containing the wild type
or mutant melAB promoters were cloned into pRW50, a low copy
number lac expression vector (13), to generate
pmelAB::lac fusions. Recombinant plasmids were
propagated in strain WAM131 (11), an mel+ strain
derived from GM-1 (14). Overexpression and Purification of His-tagged MelR--
In the
histidine-tagged variant used here (MelRH), the carboxyl terminus of
the MelR is extended by 7 amino acid residues, including 6 tandem
histidines; the full sequence of this extension is (in single-letter
code) IHHHHHH. To construct modified melR encoding the
MelRH, we started with plasmid pBM3133 (7), in which the melibiose
operon was cloned into the EcoRI site of pBR322. To insert a
unique NdeI site at the initiation codon site of the melR gene and to remove the termination codon of
melR, we used PCR mutagenesis using the primer
melR(N-NdeI) (5'-ACATATGAATACAGATACGTTTATG-3') and melR(C)
(5'-GCCGGGAAACGTCTGGCG-3'). The amplified DNA fragment was cloned into
the EcoRV site of plasmid
pBF4-11,2 which possesses a
DNA sequence encoding 6 tandem histidines after the EcoRV
site in pBluescript II SK(+). In the final step, an NdeI-BamHI fragment from the resulting plasmid
was ligated to pET30a, a T7 expression vector obtained from Novagen,
and digested with NdeI and BamHI. This generated
plasmid pETRH, in which the encoded protein acquired the extension of 7 amino acid residues noted above. The construction was organized such
that overexpressed product was initiated at the melR AUG
initiation codon. A control plasmid, pETR, carrying authentic
melR, was constructed using a similar strategy with
melR(BamHI) (5'-TGGATCCTTAGCCGGGAAACGTCTG-3') as a PCR
primer and pBluescript II SK(+) as a vector instead of melR(C) and
pBF4-11, respectively. BL21(DE3) cells (from Novagen) harboring pETRH
were used to overexpress His-tagged MelR protein. Cells from an
overnight culture were diluted 50-fold into fresh M9 medium
supplemented with 0.4% glucose, 0.2% casamino acid, and 60 mg/liter
of kanamycin (200 ml), and grown at 37 °C for 3-4 h. After the
optical density at 650 nm reached 0.8, addition of 1 mM
isopropyl
For protein purification, we used 0.5-ml bed-volume amounts of
Ni2+-agarose (Qiagen). The resin equilibrated with the
solubilization buffer was added to 9.5 ml of the solubilized protein
and kept for 30 min with gentle shaking to allow for binding of MelRH. The mixture was then placed in a column, unbound material was collected
by gravity elution, and the column was washed with 10 ml of the
solubilization buffer (pH 8.0). After nonspecifically bound material
had been removed, MelRH was eluted with the solubilization buffer (pH
6.3). The eluted protein was dialyzed against a 50-fold volume of
dialysis buffer (100 mM potassium phosphate, pH 7.4, 10%
glycerol, 50 mM KCl, 10 mM 2-mercaptoethanol, 1 mM EDTA) four times. The dialyzed protein was concentrated
by using Microcon 10 or Centricon 10 (Amicon). The purified protein was
stored at In Vitro Transcription Assays--
To measure in
vitro transcription initiation, we used the pSR plasmid vector
(12), which carries the bacteriophage Gel Retardation Assays--
Starting with plasmid pBM3133 or
pBM3133-2 as templates, PCR was used to amplify DNA fragments covering
MelR binding sites 1', 1, 2, and 2' (ET1) from the wild type
melAB promoter or the W3133-2 mutant. To do this, we used
the DNase I Footprinting Experiments--
These experiments were
performed with EcoRI-HindIII fragments carrying
the wild type or mutant mel operon regulatory region using
previously described protocols (16). Incubations contained 4-10
nM of the purified fragment that had been specifically
radiolabeled at the HindIII end using
[ In Vivo Assays with the W3133-2 Mutant melABPromoter--
In our
previous work, we described the W3133-2 mutant that results from five
consecutive base changes in the melAB promoter (7). To study
the effects of these changes in vitro, we subcloned EcoRI-HindIII DNA fragments carrying the wild
type or W3133-2 mutant melAB promoter sequences (Fig.
1). First, using PCR, we amplified the
KK81 fragment that carries the entire melAB promoter with
all four MelR binding sites (sites 1', 1, 2, and 2') that are known to
be essential for optimal melAB promoter activity (10, 11).
Second, we amplified the shorter JK14 fragment that carries the
melAB transcript start site and only the MelR binding sites
2 and 2'. In preliminary experiments, we checked the activity of the
melAB promoter carried by these fragments. To do this, the
different EcoRI-HindIII fragments were cloned
into the broad host range lac fusion vector, pRW50, and the
resulting plasmids were transformed into WAM131, a Overexpression and Purification of His-tagged MelR--
To perform
in vitro study, we needed to purify MelR. However, the
published method for purification of MelR required a large amount of
medium and a complicated column works (20). Therefore, we employed
Ni2+ affinity chromatography for the purification and T7
expression system for overexpression of MelR. First we constructed a
plasmid that carries a derivative melR encoding MelR with
the carboxyl-terminal hexahistidine tag (MelRH). The derivative
melR gene is located downstream from the T7 promoter. To
confirm that the MelRH is functional in vivo, a
XbaI-EcoRI fragment, which carries a
Shine-Dalgarno sequence was subcloned from pETRH or pETR into pMW119,
in which expression of melRH or melR is
controlled by the lac promoter. A MelR-defective mutant,
Y1089 (
For overexpression of MelRH, we used the T7 system. We tested several
media and found that M9 medium increased the expression level of our
target protein and reduced background proteins. The MelRH protein
produced in BL21(DE3)/pETRH after addition of isopropyl Activation of the melAB Promoter in Vitro using Purified
MelR--
It is important to test whether the results obtained in the
in vivo system (Table I and Ref. 7) are reproducible in the in vitro system. To do this, we cloned
EcoRI-HindIII DNA fragments carrying the wild
type or W3133-2 mutant melAB promoter sequences into the pSR
vector plasmid, which carries the bacteriophage Gel Retardation Assays--
It had previously been noted that the
base changes in the melAB promoter in the W3133-2 mutant
changed the DNA sequence of MelR binding site 2' such that it
corresponded better to the tighter binding sites 1', 1, and 2. Therefore, gel retardation assays were used to measure the binding of
purified MelR to the different sites at the wild type or W3133-2 mutant
melAB promoter. In the first experiment (Fig.
3A), we measured the binding
of MelR to ET1 fragments carrying MelR binding sites 1', 1, 2, and 2'
(the ET1 fragments were made using PCR with the DNase I Footprinting Experiments--
To confirm the conclusions
from gel retardation assays, we used DNase I footprinting to study the
binding of purified MelR to the JK14 fragment carrying the wild type or
W3133-2 mutant melAB promoter sequences. The results (Fig.
4) show that, with the wild type
melAB promoter sequence, MelR affords clear protection of
the segment of DNA corresponding to MelR binding site 2. However, even
in the presence of melibiose and higher concentrations of MelR, very
poor protection of the segment of DNA corresponding to MelR binding
site 2' is observed. However, with the JK14 fragment derived from the
W3133-2 mutant, clear protection of both site 2 and site 2' is seen,
even in the absence of melibiose.
From our results, we conclude that, as predicted, the five
base changes in the melAB promoter of the W3133-2 mutant
improve the binding of MelR to site 2'. We suppose that this
improvement in MelR binding is responsible for the increased
melAB promoter activity in the W3133-2 mutant, although we
cannot prove that it is solely responsible. In our previous paper, we
noted that the five base changes in the W3133-2 mutant create an
extended 28-nucleotide inverted repeat at the melAB promoter
(7). We suggested that this inverted repeat might facilitate the
formation of a stem-loop structure and that this may be responsible for the increased melAB promoter activity in the W3133-2 mutant.
However, our observation that the increased melAB promoter
activity is observed even in the absence of MelR binding sites 1' and 1 (i.e. with the JK14 fragment, which lacks the extended
inverted repeat) proves that this cannot be the case. Indeed, the
effects of the five base changes are greater with the JK14 fragment:
this appears to be because MelR binding to site 2' is aided by MelR
binding to sites 1' and 1, and thus, in the absence of sites 1 and 1', improvement of site 2' has a proportionately greater effect.
Taken together, our results show that the activity of the
melAB promoter is limited by the binding of MelR to site 2'.
Because this site overlaps the
120.5,
100.5,
62.5, and
42.5 upstream of the transcript start point. In
a previous study, we described a spontaneous mutant that exhibited
increased melAB expression. Sequence analysis showed that
this mutant carries five consecutive base changes at positions
49,
50,
51,
52, and
53 upstream of the melAB transcript
start. Here we show that these changes improve MelR binding to the
target site centered at position
42.5 at the melAB promoter and that this improvement is responsible for increased promoter activity. Thus, the activity of the melAB promoter
is fixed by the occupation by MelR of a DNA site that overlaps the
35
hexamer: MelR appears to be a typical class II-type transcription activator.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase, whereas melB encodes a melibiose
transporter (1-5). An unusual feature of E. coli K12
strains is that they are able to metabolize melibiose at 30 °C, but
they become progressively less able to metabolize melibiose at
temperatures above 37 °C, due to thermal lability of the
melB melibiose transporter (6). In recent work (7), we have
studied the W3133-2 mutant that is able to grow at higher temperatures
with melibiose as the sole carbon source. Although we had expected that
the melB gene in this mutant would be altered in some way,
we found that the W3133-2 mutant carried five consecutive base changes
in the melAB promoter. We showed that these changes led to
an increase in expression of the melAB operon at all
temperatures and that this increase, apparently, could compensate for
the thermolability of the melB melibiose transporter (7).
The principal objective of the work presented here has been to
understand the effects of the base changes in the W3133-2 mutant.
120.5,
100.5,
62.5, and
42.5, respectively, upstream
of the melAB transcript start point (Fig. 1). Recent studies
(11) have shown that the occupation of site 2' by MelR is the most
crucial for the activation of the melAB promoter, but that,
of the four target sites, site 2' binds MelR most weakly. We noted that
the base changes in the melAB promoter in the W3133-2 mutant
changed the DNA sequence of MelR binding site 2' such that it
corresponded better to the tighter binding site 1', site 1, and site 2. This suggested that the increased melAB expression in the
W3133-2 mutant could be due to better binding of MelR to site 2'. In
the work reported here, we prove that this is indeed the case, by
studying the binding of purified MelR and purified RNA polymerase
holoenzyme (RNAP)1 to DNA
fragments carrying the melAB promoter from both the wild type and W3133-2 mutant strain
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
312 with respect to the melAB transcript start, and a HindIII site at +36 was generated using the
primers 5'-GCAGAATTCCGGGCTGCGGGT-3' and
5'-GCAAAGCTTGGATGCAGGTCGACGGATCTC-3' (see Fig. 1). The shorter JK14
fragment, with an EcoRI site at position
94 with respect to the melAB transcript start, and a HindIII site
at +36, was made with the primers 5'-GCAGAATTCGATTTACTGCTGCTTCACG-3'
and 5'-GCAAAGCTTGGATGCAGGTCGACGGATCTC-3' (see Fig. 1). PCR
products carrying wild type or W3133-2 mutant sequences were restricted
with EcoRI and HindIII and cloned either into
plasmid vectors pSR (12) or pRW50 (13).
-Galactosidase levels in these cells were
measured using the method of Miller (15): cells were grown in media
either with or without melibiose exactly as in our previous work
(5).
-D-thiogalactopyranoside allowed induction of
MelRH during the following 3- to 4-h incubation. All subsequent work
was done at 4 °C. After cells were harvested by centrifugation, and
they were resuspended 10 ml of sonication buffer (100 mM
potassium phosphate, pH 8.3, 200 mM KCl, 10% glycerol, 10 mM 2-mercaptoethanol, 1 mM EDTA) and subjected
to lysis by ultrasonication (15 s × 12 times with 10-s
intervals). After centrifugation at 22,500 × g for 20 min, inclusion body was resuspended in the same volume of the
sonication buffer containing 4% Triton X-100 and recentrifuged at
22,500 × g for 20 min. The inclusion body was washed
twice with the sonication buffer, and finally the inclusion body was solubilized in 10 ml of solubilization buffer (100 mM
potassium phosphate, 200 mM KCl, 6 M
guanidine-HCl, 10% glycerol, 1 mM 2-mercaptoethanol, 1 mM EDTA, pH 8.3). After centrifugation at 22,500 × g for 20 min, the supernatant fraction was kept at
20 °C until use.
70 °C until use.
oop transcription
terminator just downstream of the EcoRI and
HindIII cloning sites. Transcription experiments were
performed using the protocols described by Kolb et al. (12).
The KK81 or JK14 EcoRI-HindIII fragments
containing the wild type or mutant melAB promoters were
cloned into pSR such that transcripts initiating at the
melAB promoter would run to the
oop
terminator. The resulting recombinants were purified by cesium chloride
centrifugation and used as template for RNA synthesis. The
preincubation mixtures contained 10 nM supercoiled plasmid
DNA template in 20 mM Tris-HCl, pH 8.0, 5% glycerol, 100 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 1 mM dithiothreitol, and 50 µg/ml
bovine serum albumin. Up to 1500 nM MelR and 10 mM melibiose (as appropriate) were added and incubated for
10 min at 37 °C. The incubation was continued with the addition of
20 nM purified RNAP (supplied by Amersham Pharmacia
Biotech) for a further 5 min, prior to the addition of 200 µM ATP, CTP, and GTP, 10 µM
-32P-labeled UTP, and 100 µg/ml heparin. After an
additional 5-min incubation, 32P-labeled RNA was analyzed
on calibrated polyacrylamide sequencing gels. Transcription initiation
at the melAB promoter gives rise to an easily detectable
discrete transcript that terminates at the oop terminator,
with the control RNA I from the pSR ColE1 origin acting as an internal
control. Transcripts were quantified with the aid of a PhosphorImager
(Molecular Dynamics, Inc.).
160 primer (5'-CGAGGGGACTCTCCGAGTATC-3') together with the
10
primer (5'-TAACTTCATCATGGCAGGCGA-3') shown schematically in Fig. 1.
Before the PCR reaction, the
160 primer was end-labeled with
32P using T4 polynucleotide kinase. The labeled PCR product
was used as a probe in gel retardation assays. Incubation mixtures contained 32P-labeled DNA probe and purified His-tagged
MelR in 50 mM Tris-HCl, pH 7.4, 50 mM KCl, 10%
glycerol, 0.1 mg/ml sheared salmon sperm DNA, 10 mM
melibiose, 1 mM EDTA, and 1 mM dithiothreitol.
After incubation for 5 min at 37 °C, samples were applied to 5%
polyacrylamide gels that were run in standard Tris-borate/EDTA
electrophoresis buffer at 150 V. After electrophoresis, gels were
fixed, dried, and exposed to x-ray film. Gel retardation assays were
also performed with the shorter ET2 and ET3 probes illustrated in Fig.
1. These probes were made by annealing the appropriate complementary
oligos after 5'-end labeling with 32P using T4
polynucleotide kinase.
-32P]ATP and polynucleotide kinase, and different
amounts of purified His-tagged MelR and melibiose as indicated. After
DNase I treatment, footprint patterns were analyzed on polyacrylamide
sequencing gels that were calibrated with Maxam-Gilbert sequence ladders.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
lac
mel+ strain derived from GM-1 (11, 14). Expression of
the promoter melAB::lacZ fusions
carried by the pRW50 recombinants was measured in transformants grown
either with or without the inducer, melibiose. The results, listed in
Table I, indicate that, with the longer KK81 fragment, expression from the melAB promoter is clearly
induced by melibiose and that the W3133-2 mutant promoter is 8- to
9-fold more active than the wild type promoter. With the shorter JK14 fragment, the removal of MelR binding sites 1' and 1 results in a
4-fold reduction in expression of the melAB promoter.
However, in contrast, with the W3133-2 mutant, melAB
promoter activity is only slightly affected by removal of MelR binding
sites 1' and 1. Thus, the base changes in the W3133-2 mutant result in a >20-fold increase in melAB promoter activity in the
context of the shorter JK14 fragment. These results show that the
effects of the base changes in the W3133-2 mutant are easily detected in short fragments and encouraged us to attempt in vivo
studies.

View larger version (24K):
[in a new window]
Fig. 1.
The E. coli mel operon
regulatory region. A, a diagram of the intercistronic
region between the divergently transcribed melA and
melR genes: horizontal arrows indicate the
corresponding transcription start sites. DNA sequences are numbered
with respect to the melAB transcript start as +1. The
melAB promoter
10 and
35 hexamers are indicated by
open rectangles. The figure illustrates the KK81 fragment
bounded by an upstream EcoRI site at position
312 and a
downstream HindIII site at position +36, and the JK14
fragment bounded by an upstream EcoRI site at position
94
and a downstream HindIII site at position +36. The locations
of the DNA sites for MelR are indicated by triangles: each
triangle indicates an 18-base pair sequence and its
orientation, and the position of the center of each site is denoted.
Filled triangles, sites 1 and 2, which have identical
sequences; gray triangles, site 1' and the related site R
that overlaps the melR promoter; open triangle,
weak site 2' that is discussed here. The locations of the
160 and
10 primers, which were used to generate ET1 probes for the gel
retardation assays are shown. B, shows the DNA sequence
around MelR binding sites (sites 1', 1, 2, and 2') in the wild type
melAB promoter and in the W3133-2 mutant. The consecutive
five-nucleotide mutation is shown with bold letters. The
underlined sequences between sites 1' and 2, and those
between sites 1 and 2', are identical. The location of the ET2 and ET3
probes used in the gel retardation assays are also indicated.
Transcription activation of the melAB promoter
-Galactosidase activities (in Miller units) were measured in WAM131
cells containing pRW50 carrying the KK81 or JK14 fragments with the
wild type or W3133-2 mutant melAB promoter sequences. The
measured activities are indicative of the expression of
melAB promoter::lac fusions carried by
the pRW50 derivatives. Cells were grown in minimal media with fructose
as a carbon source either with or without melibiose exactly as in our
previous work (5). Data shown are the average values from three
independent experiments.
melR) (19), harboring either one of the
constructed plasmids, formed similar red colonies on a
MacConkey-melibiose (5 mM) plate (data not shown). This
result indicates that the MelRH worked as a transcription activator for the melibiose operon in vivo. Other results from gel
retardation assay and in vitro transcription assay done with
MelR or MelRH indicated that MelRH had almost the same DNA binding
affinity and transcription activation activity as wild type MelR (data not shown).
-D-thiogalactopyranoside reached about 10-20% of total
cell protein. However, most of the overproduced MelRH protein formed
inclusion body. The advantage of this preparation was that the MelRH in the inclusion body was more than 80% pure without any column works. The inclusion body was solubilized with 6 M guanidine
buffer and purified using Ni2+-agarose. The purified
protein was renatured by dialysis and then concentrated by
ultrafiltration. When concentration of the purified MelRH was high,
precipitation occurred during dialysis and most protein bound to filter
during ultrafiltration. Our protocol yielded 500 µg of
95% pure
His-tagged MelR from 200 ml of culture. This amount is enough for
in vitro analysis. The renatured MelRH showed almost
identical transcription activation activity as that observed with MelR
purified by the method reported previously (19) without denaturation
(data not shown).
oop
transcription terminator just downstream of the HindIII site (12). The resulting recombinant plasmids were used to monitor MelR-dependent activation at the melAB promoter;
i.e. transcripts initiating at the melAB promoter
run to the
oop terminator and give discrete transcripts
that are easy to detect by gel electrophoresis. In addition, because
pSR contains a ColE1 replication origin, the RNA I transcript can be
used as an internal control to aid quantification of
MelR-dependent transcripts. Fig.
2 shows the results from a typical
experiment, where purified RNAP, together with purified MelR and
melibiose, was preincubated with purified circular pSR plasmid carrying
the JK14 or KK81 insert, prior to the addition of labeled nucleoside
triphosphates. Each incubation produces the control RNA I transcript,
but a longer transcript originating at the melAB transcript
start is seen when the preincubation includes purified MelR and
melibiose. With both the JK14 and KK81 inserts, more transcript
initiating at the melAB promoter is observed with template
from the W3133-2 mutant. We have done three sets of the same experiment
and two sets of an experiment in which concentration of RNA polymerase
was increased to 150 nM. All of the results were almost
identical to the result in Fig. 2. From these experiments, we conclude
that the effects of the base changes in the W3133-2 mutant can be
reproduced, at least partially, in vitro.

View larger version (39K):
[in a new window]
Fig. 2.
In vitro transcription initiation
at the melAB promoter. The figure shows
autoradiographs of gels on which RNA synthesized in vitro by
E. coli RNAP was analyzed. The template is the pSR plasmid
carrying the KK81 or JK14 inserts carrying the wild type or W3133-2
mutant melAB promoter sequences. The locations of the
"constitutive" RNA I transcript and the transcript starting at the
melAB promoter are indicated. The preincubations contained
melibiose (10 mM) and different concentrations of purified
MelR as indicated. The lower part shows quantification of
the transcript starting at the melAB promoter in the
different experiments relative to the RNA I transcript.
160 and
10 primers and pBM3133 or pBM3133-2 as templates: see Fig. 1). With the wild type
ET1 fragment, four retarded bands are observed, with the most retarded
bands appearing at higher MelR concentrations. We attribute these bands
to progressive occupation of the four DNA sites for MelR: as expected,
the fourth, most retarded band remained quite weak, in agreement with
our previous observation that MelR binds weakly to site 2'. However,
with the ET1 fragment from the W3133-2 mutant, this fourth retarded
band appears much stronger, suggesting that the base changes in the
mutant have tightened the binding of MelR to site 2'. The second
experiment (Fig. 3B) with the shorter ET2 fragment, carrying
only MelR binding sites 2 and 2', confirmed this interpretation: with
the fragment derived from the wild type melAB promoter, two
retarded bands are observed, with only a small amount of the more
retarded band appearing at higher MelR concentrations. However, with
the ET2 fragment from the W3133-2 mutant, this second more retarded
band appears much stronger. Finally, the control experiment (Fig.
3C) with the ET3 fragment carrying only MelR binding site 2 shows just one retarded band that is unaffected by the base changes
from the W3133-2 mutant. Note that the version of this fragment derived
from the mutant does contain the five base changes (see Fig. 1), but
these do not affect MelR binding to site 2. It should also be noted
that MelR did not bind to the fragment carrying just site 2' (data not
shown).

View larger version (30K):
[in a new window]
Fig. 3.
Gel retardation studies. Autoradiographs
of gel retardation experiments to measure the binding of purified MelR
to different DNA fragments. A, binding to ET1 probes
carrying MelR binding sites 1', 1, 2, and 2' from the wild type or
W3133-2 mutant melAB promoter. B and
C, binding to the ET2 or ET3 probes from the wild type or
W3133-2 mutant melAB promoter. The quantities of MelR used
in each incubation are indicated.

View larger version (128K):
[in a new window]
Fig. 4.
DNase I footprint analysis of MelR
binding. An autoradiograph of a sequencing gel run to analyze
products after DNase I cleavage of complexes formed by MelR at the JK14
fragment from the wild type or W3133-2 mutant melAB
promoter. The quantities of MelR used in each incubation are indicated.
Maxam-Gilbert sequencing reactions were used to calibrate the gel. The
calibration that is shown takes the melAB transcript start
point as +1, and the vertical bars indicate the locations of
MelR binding sites 2 and 2'.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
35 hexamer of the melAB
promoter, it appears that MelR, like AraC and many other members of the
AraC family, may be a typical "Class II" transcription activator
(17). Our results suggest that the principal function of the upstream
sites 1' and 1 is to help the occupation of site 2'. Thus, the
requirement of sites 1' and 1 for melAB promoter activity is
greatly reduced when MelR binding site 2' is improved (Table I). It is
known that Class II transcription activators function by making a
direct contact with Region 4 of the RNAP
subunit (18). Thus, the challenge now is to understand the molecular details of the MelR-
subunit interactions.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Victoria Howard, Eva Hyde, and Joseph Wade of The University of Birmingham for many helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the Ministry of Education, Science and Culture of Japan and from the United Kingdom Biotechnology and Biological Sciences Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama, 700-8530 Japan. Tel./Fax: 81-86-251-7957; E-mail: tsuchiya@pheasant.pharm.okayama-u.ac.jp.
Published, JBC Papers in Press, March 21, 2000, DOI 10.1074/jbc.M000499200
2 E. Tamai, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RNAP, RNA polymerase holoenzyme; PCR, polymerase chain reaction.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Prestidge, L., and Pardee, A. (1965) Biochim. Biophys. Acta 100, 591-593 |
| 2. | Schmitt, R. (1968) J. Bacteriol. 96, 462-471 |
| 3. | Levinthal, M. (1971) J. Bacteriol. 105, 1047-1052 |
| 4. | Hanatani, M., Yazyu, H., Shiota-Niiya, S., Moriyama, Y., Kanazawa, H., Futai, M., and Tsuchiya, T. (1984) J. Biol. Chem. 259, 1807-1812 |
| 5. | Webster, C., Kempsell, K., Booth, I., and Busby, S. (1987) Gene 59, 253-263 |
| 6. | Tsuchiya, T., Lopilato, J., and Wilson, T. (1976) J. Membr. Biol. 42, 45-59 |
| 7. | Tamai, E., Shimamoto, T., Tsuda, M., Mizushima, T., and Tsuchiya, T. (1998) J. Biol. Chem. 273, 16860-16864 |
| 8. | Webster, C., Gardner, L., and Busby, S. (1989) Gene 83, 207-213 |
| 9. | Webster, C., Gaston, K., and Busby, S. (1988) Gene 68, 297-305 |
| 10. | Williams, J., Michán, C., Webster, C., and Busby, S. (1994) Biochem. J. 300, 757-763 |
| 11. | Belyaeva, T., Wade, J., Webster, C., Howard, V., Thomas, M., Hyde, E., and Busby, S. (2000) Mol. Microbiol. 36, 211-222 |
| 12. | Kolb, A., Kotlarz, D., Kusano, S., and Ishihama, A. (1995) Nucleic Acids Res. 23, 819-826 |
| 13. | Lodge, J., Fear, J., Busby, S., Gunaseker, P., and Kamini, N-R. (1992) FEMS Microbiol. Lett. 95, 271-276 |
| 14. | Coulondre, C., and Miller, J. (1977) J. Mol. Biol. 117, 525-575 |
| 15. | Miller, J. (1972) Experiments in Molecular Genetics , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 16. | Savery, N., Belyaeva, T., and Busby, S. (1996) Essential Techniques: Gene Transcription (Docherty, K., ed) pp. 1-5, 21-33, BIOS Scientific Publishers, Oxford |
| 17. | Gallegos, M.-T., Schleif, R., Bairoch, A., Hofmann, K., and Ramos, J.-L. (1997) Microbiol. Mol. Biol. Rev. 61, 393-410 |
| 18. | Rhodius, V., and Busby, S. (1998) Curr. Opin. Microbiol. 1, 152-159 |
| 19. | Bourgerie, S., Michán, C., Thomas, M., Busby, S., and Hyde, E. (1997) Nucleic Acids Res. 25, 1685-1693 |
| 20. | Caswell, R., Williams, J., Lyddiatt, A., and Busby, S. (1992) Biochem. J. 287, 493-499 |
This article has been cited by other articles:
![]() |
J. A. Ibarra, M. I. Villalba, and J. L. Puente Identification of the DNA Binding Sites of PerA, the Transcriptional Activator of the bfp and per Operons in Enteropathogenic Escherichia coli J. Bacteriol., May 1, 2003; 185(9): 2835 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peralta-Gil, D. Segura, J. Guzman, L. Servin-Gonzalez, and G. Espin Expression of the Azotobacter vinelandii Poly-{beta}-Hydroxybutyrate Biosynthetic phbBAC Operon Is Driven by Two Overlapping Promoters and Is Dependent on the Transcriptional Activator PhbR J. Bacteriol., October 15, 2002; 184(20): 5672 - 5677. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Howard, T. A. Belyaeva, S. J. W. Busby, and E. I. Hyde DNA binding of the transcription activator protein MelR from Escherichia coli and its C-terminal domain Nucleic Acids Res., June 15, 2002; 30(12): 2692 - 2700. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |